ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO510

A Feasibility Study Investigating the Role of Kidney Failure Risk Equation in Optimizing the Timing of Vascular Access Creation

Session Information

  • Dialysis Vascular Access
    October 25, 2024 | Location: Exhibit Hall, Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: Dialysis

  • 803 Dialysis: Vascular Access

Authors

  • Atiquzzaman, Mohammad, The University of British Columbia, Vancouver, British Columbia, Canada
  • Zhu, Bingyue, BC Provincial Renal Agency, Vancouver, British Columbia, Canada
  • Er, Lee, BC Provincial Renal Agency, Vancouver, British Columbia, Canada
  • Romann, Alexandra, BC Provincial Renal Agency, Vancouver, British Columbia, Canada
  • Djurdjev, Ognjenka, BC Provincial Renal Agency, Vancouver, British Columbia, Canada
  • Levin, Adeera, The University of British Columbia, Vancouver, British Columbia, Canada
Background

KFRE 2-year risk threshold of >40% along with existing eGFR based referral for vascular access (VA) creation may improve VA resource utilization. We investigated if KFRE score can play a role in optimizing the timing of VA creation.

Methods

We analyzed a cohort of 2,581 patients with CKD who had an eGFR of <20 ml/min/1.73m2 and chose hemodialysis (HD) as their preferred mode of dialysis. We created the cohort using data from PROMIS, a population-level registry database for patients with CKD in BC, Canada. Modality selection date was index date. In step 1, we explored the association between KRFE-2 threshold and timing of HD initiation among patients who reached kidney failure and initiated HD within 24 months from the index date in two ways: First, we categorized the patients based on time to HD initiation into 0-3, 3-6, 6-9, 9-12 and 12-24 months, and investigated the corresponding distribution of KFRE-2 scores at index. Second, we categorized the patients based on index KFRE-2 score into <40%, 40-<50%, 50-<60%, 60-<70%, 70-<80% and >80% and investigated the distribution of time to HD initiation. In step 2, we explored the positive predictive value (PPV) of initiating HD within 6 and 24 months using the aforementioned KFRE-2 thresholds among the entire cohort.

Results

Study cohort included 2581 patients, median age 71 years, and 40% female. Of the 1,562 patients who initiated HD within 2 years, a total of 733 (47%) patients initiated HD within 6 months and the median index KFRE-2 was ≥69% (Table 1A). On the other hand, 207 (13%) patients had an index KFRE-2 of 60 - <70% and the median time to initiate HD was 6.4 months (Table 1B). PPV gradually increased with increasing KFRE-2 threshold for both HD initiation within 6 and 24 months (Fig 1).

Conclusion

KFRE-2 score has the potential to guide the timing of VA creation. Future research using sophisticated methodology is required to identify an optimal KFRE-2 score for fistula/graft creation.